1Chugh SS,Blsckshear JL,Shen WK,et al.Epidemiology and natural history of atrial fibrillation clinical implications[J].J Am Coil Cardiol,2001,37(2):371-378.
2Bruins P,te Velthuis H,Yazdanbakhsh AP,et al.Activation of the complement system during and after cardiopulmonary bypass surgery:postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia[J].Circulation,1997,96(10):3542-3548.
3Ahlsson AJ,Bodin L,Lundblad OH,et al.Postoperative atrial fibrillation is not correlated to C-reactive protein[J].Ann Thorac Surg,2007,83 (4):1332-1337.
4Chung MK,Martin DO,Sprecher D,et al.C-reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillation[J ].Circulation,2001,104(24):2886-2891.
5Dernellis J,Panaretou M.C-reactive protein and paroxysmal atrial fibrillation:evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation[J].Acta Cardiol,2001,56(6):375-380.
6Aviles RJ,Martin DO,Apperson-Hansen C,et al.Inflammation as a risk factor for atrial fibrillation[J].Circulation,2003,108(24):3006-3010.
7Dernellis J,Panaretou M.C-reactive protein and paroxysmal atrial fibrillation:evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation[J].Acta Cardiol,2001, 56(6):375-380.
8Sata N,Hamada N,Horinouchi T,et al.C-reactive protein and atrial fibrillation.Is inflammation a consequence or a cause of atrial fibrillation?[J].Jpn Heart J,2004,45(3):441-445.
9Frustaci A,Chimenti C,Bellocci F,et al.Histological substrate of atrial biopsies in patients with lone atrial fibrillation[J].Circulation,1997,96(4):1180-1184.
10Watanabe E,Arakawa T,Uchiyama T,et al.High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion[J].Int J Cardiol,2006,108(3):346-353.
3Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 19991 implications for primary prevention [J]. Circulation, 2003,108(6) : 711-716.
4Mahajan R, Brooks AG, Sullivan T, et al. Importance of the underlying substrate in determining thromhus location in atrial fibrillation: implications for left atrial appendage closure[J]. Heart,2012,98(15) : 1120-1126.
5Handke M, Harloff A, Hetzel A, et al. Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation-a transesophageal echocardiographic study in 500 patients withcerebral ischemia [J]. Am Soc Eehocardiogr, 2005,18 (12): 1366-1372.
6Tanaka K, Yamada T. Pre-admission CHADS2, CHA2DS2- VASc, and R2CHADS2 scores on severity and functional outcome in acute ischemic stroke with atrial fibrillation stroke [J]. Cerebrovasc Dis, 2015,24(7) : 1629-1635.
7Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study[J]. Stroke, 1991,22(8) : 983-988.
8Wasilewska M, Gosk-Bierska I. Thronrboenrbolism associated with atrial fibrillation as a cause of limb and organ ischemia [J]. Adv Clin Exp Med,2013,22(6) :865-873.
9Friberg L,Rosenqvist M,Lindgren A, et al. High prevalence of atrial fibrillation among patients with ischemic stroke [J ]. Stroke, 2014,45 (9) : 2599-2605.
10Goldman ME, Pearce LA, Hartz RG, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-m ] study)[J]. Am Soc Echocardiogr, 2000, 12(12): 1080-1087.
